You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 May 2022 - - To support the Greater Boston biotech ecosystem, US-based lab instrument maker Thermo Fisher Scientific (NYSE: TMO) is joining forces with biotech incubator LabShares Newton to provide instruments, lab equipment and consumab...
20 May 2022 - - The US FDA has approved of a supplemental New Drug Application for Annovera, US-based TherapeuticsMD, Inc. (NASDAQ: TXMD) said.
The sNDA included minor revisions to Annovera's in vitro release testing spe...
The sNDA included minor revisions to Annovera's in vitro release testing spe...
20 May 2022 - - US-based life sciences and materials science company Schrödinger, Inc. (NASDAQ: SDGR), whose physics-based software platform is used for therapeutics and materials discovery, has appointed Arun Oberoi to its board of directors, t...
20 May 2022 - - US-based clinical-stage company Nimbus Therapeutics has presented new data from multiple Phase 1 clinical studies of its investigational oral allosteric tyrosine kinase 2 inhibitor, NDI-034858, in both healthy volunteers and patients ...
20 May 2022 - - US-based clinical stage gene therapy company Myrtelle Inc has entered into a worldwide exclusive licensing agreement with Rescue Hearing Inc. to develop a novel gene therapy for DFNB8 genetic hearing loss, the company said.
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe